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There is increasing evidence that, in addition to their presence, the propensity of circulating tumour cells to form multi-cellular
clusters bears significant information about both cellular resistance to chemotherapy and overall prognosis. We present a novel
two-stage, stopped-flow, continuous centrifugal sedimentation strategy to measure the size distributions of events (defined here
as cells or clusters thereof) in a blood sample. After off-chip removal of red blood cells, healthy white blood cells are sequestered
by negative-immunocapture. The purified events are then resolved along a radially inclined rail featuring a series of gaps with
increasing width, each connected to a designated outer collection bin. The isolation of candidate events independent of target-
specific epitopes is successfully demonstrated for HL60 (EpCAM positive) and sk-mel28 (EpCAM negative) cells using identical
protocols and reagents. The propensity to form clusters was quantified for a number of cell lines, showing a negligible, moderate
or elevated tendency towards cluster formation. We show that the occupancy distribution of the collection bins closely correlates
with the range of cluster sizes intrinsic to the specific cell line.
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INTRODUCTION
The presence of circulating tumour cells (CTCs) in the blood of a
patient, as found in most forms of epithelial cancer1–5, has been
identified as a reliable indicator of the prognosis of various cancer
types. More recently, the propensity of CTCs to occur in multi-
cellular clusters (sometimes referred to as circulating tumour
microemboli or CTM) has been observed by a number of groups
using a number of technologies. On examination, the occurrence of
such clusters can provide important information about patients’
outcomes, as these clusters appear to increase the risk of
metastasis6,7. The associated surge in metastatic potential is
dramatically increased, by up to 50-fold, when the outcome of
mice that have been injected with either single CTCs or CTC clusters
is observed6,8. The biological processes that result in CTC clusters
having a higher metastatic potential than single CTCs do are still
under investigation; nevertheless, studies have provided interesting
results suggesting that the microenvironment generated by the
multi-cellular nature of the clusters provides certain protection from
physiological processes that normally compromise the viability of
single CTCs. As the number of single CTCs is far in excess of the
number of metastatic lesions that develop in a patient, it can be
inferred that the majority of CTCs are either inert (from a metastatic
perspective) or do not survive long enough to seed a new lesion.
Most CTCs are probably lost through anoikis (a form of apoptosis in
which cells lose cell–cell or cell–matrix interactions) or stresses
induced by shear forces in the blood. However, CTCs within a cluster
have been shown to resist anoikis/apoptosis, possibly due to the
maintenance of cell–cell junctions within the cluster and protection
from shear forces by virtue of the outer cells7,9,10. Furthermore,
molecular investigations of the cells within a cluster have shown
elevated levels of pro-survival9 and pro-epithelial-to-mesenchymal
transition signals11. These clusters’ genesis is still under investigation,
but studies have proposed that rather than emerging from the
proliferation of a single CTC or from aggregation in the bloodstream,
clusters may represent tissue that breaks away from the site of a
primary tumour6,7. CTCs’ lack of proliferation therefore (theoretically)
renders these cells resistant to chemotherapies that actively target
rapidly dividing cells, thus increasing the diagnostic and prognostic
potential of identifying the cluster load in a blood sample.
A number of microfluidic systems for isolating candidate CTC
events have been developed, as reviewed by Yu et al. 12. In these
systems, various strategies have been employed and combined to
isolate CTCs from blood, including epitope-specific capture13–15,
epitope-specific magnetic bead binding16–19 and physical isolation
based on size20,21 and/or deformability22,23. The majority of micro-
fluidic lab-on-a-chip systems in which clusters have been isolated
seem to have been originally designed for the isolation of single
CTCs. However, by virtue of fortuitously and efficiently designed
tolerance to size, CTC clusters have sometimes been co-isolated
along with the single events14,24. The size ranges of clusters
retrieved in these systems were elucidated by scanning the capture
regions of the chips microscopically and reporting the cell count in
each captured cluster on an individual basis. The HB-chip developed
by Stott et al.14 was recently advanced to allow more efficient
isolation of CTC events, and concordantly, the geometry of this new
CTC-iChip was chosen to capture clusters in addition to single-cell
events. However, individual optical identification of clusters was still
required to quantify the clusters’size25.
To the best of our knowledge, the current work is the first to
present a proof-of-concept strategy for directly estimating the
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size range of CTC clusters in a blood sample without the need to
serially examine and enumerate each individual event. Blood
samples are initially processed off-chip using standard laboratory
protocols to remove red blood cells (RBCs), and negative-mode
isolation with specifically functionalised magnetic beads is used to
remove non-CTC candidate events. Negative-mode isolation25–27 is
chosen to circumvent the issues that arise due to the inherent
phenotypic heterogeneity of these events when directly targeting
CTC candidates. Using stopped-flow centrifugal particle sedimenta-
tion, CTC events (single- and multi-cellular) are binned into discrete
collection chambers that are individually connected to a differen-
tial size-filtration structure along a rail. As cellular clusters are
absent in healthy blood, qualitative analysis of the collection
chambers correlates with the frequencies of cluster sizes present
in the original sample that was loaded into the cartridge. Simple
digital interpretation of the occupancy of the collection bins (i.e.,
assigning “1” to an occupied bin and “0” to an empty bin) allows
quantification of the CTC cluster distribution.
OPERATIONAL PRINCIPLE
Analysis of a sample is arranged in two stages: initial off-chip
blood processing, followed by an on-chip differential size-sorting
step. After hypotonic RBC lysis using standard protocols, CTC
events are purified through bead-based, immuno-magnetic
removal of normal, non-CTC candidate cells. This negative mode
was chosen to offset the inherent heterogeneity within CTC
populations due to the lack of known epitopes that are common
to all CTCs. For example, EpCAM-expressing cells in the blood are
commonly used in positive isolation strategies for the identifica-
tion of CTCs. However, certain CTCs do not express EpCAM, and
indeed, in many carcinomas, EpCAM is under expressed or even
absent28.
For the negative-mode isolation used here, white blood cells
(WBCs) are incubated with a mixture of CD15- and CD45-specific
super-paramagnetic beads, which bind to all naturally occurring
WBCs. Abnormal events (CTC or CTC-based cluster candidates)
lack expression of CD15 and CD45 and therefore remain
unbound. Healthy WBCs are then gently eliminated from the
solution by placing the tube in proximity to a magnet (Supple-
mentary Figure S1). The small numbers of abnormal cellular
events that remain suspended are forwarded into the second
phase. The entire, dead-end microfluidic cell-sorting chamber is
first fluidic ally primed so that the system operates in stopped-
flow sedimentation mode. The isolated abnormal events are
introduced via the loading port. Next, the disc is spun at 12 Hz for
25 min. Upon exiting the sample-loading chamber, events are
guided along the size-exclusion rail, which is inclined with respect
to the direction of the centrifugal field (Figure 1a, green box). This
rail is composed of flat-edged pillars featuring interspersed gaps
of successively increasing size that gate the entry. The paths to
the outer bins are aligned parallel to the radial direction so that
events penetrating the rail centrifugally sediment straight to the
base. The gate size successively increases from 4.7 μm in the
initial bin (which isolates debris and highly deformable cells) to
130 μm in the last of the eight bins, as defined in Figure 1a. The
aperture sizes of the rails were inspired by the size distribution of
native blood cells in relation to cancer cells. For example, it is
anticipated that the fragments of RBCs that are present following
hypotonic lysis as well as platelets (2–3 µm) would resolve to the
first bin, i.e., the smallest aperture bin. Any remaining WBCs (9–15
µm) would then resolve to the second bin. Thereafter, cancer cells
and multi-cellular events will occupy the subsequent bins (bins
3–8). Events that resolve to the base of the collection bins can be
observed by microscopy.
Arrays of shaped pillars have been previously used in the
microfluidics literature to separate materials, using either a
filtering strategy based on gap sizes29 or the so-called determin-
istic lateral displacement approach, in which material ranging
from DNA molecules30 to beads31 to cells32 has been successfully
separated. However, to the best of our current knowledge, the
strategy presented here is the first to combine shaped pillars and
a centrifugal sedimentation mode (i.e., in the absence of flow) to
specifically generate data to measure the event-size distribution
in a cellular sample via a collective approach, i.e., without the
requirement of serial testing of individual captured events.
MATERIALS AND METHODS
Standard protocols for disc fabrication, polydimethylsiloxane
priming, blood processing and cell culture were used and have
been described elsewhere33–37. These protocols are also briefly
outlined in the Supplementary Information.
DynabeadTM CD15/CD45-mediated negative selection
of normal WBCs
Negative selection-based removal of normal WBCs was carried out on
spiked and non-spikedWBC samples that were prepared as described
in the “Materials and Methods” section of the ESI. Following the
removal of RBCs, each WBC sample was placed into a 15-ml
disposable centrifuge tube (Sarstedt, Nümbrecht, Germany), and the
volumewas adjusted to 14ml using priming buffer. In total, 16 and 80
µl of CD15- and CD45-specific magnetic Dynabeads® (Life Technolo-
gies, Carlsbad, CA, USA), respectively, were added to the tube. A
double layer of Parafilm (Pechiney Plastic Packaging Company,
Chicago, IL, USA) was placed between the cap and the tube, which
was then rotated on a SB2 Rotator (Stuart, Staffordshire, UK) at 20 rpm
for 10 min at an angle of 15° from the vertical at room temperature.
After incubation, the bead-bound WBCs were immobilized by
placing the tube horizontally onto a flatbed rocker (Stuart, UK)
operated at 45 Hz. A strong N45 NdFeB permanent magnet (30 
30 15mm3, Supermagnete, Gottmadingen, Germany) was slowly
lowered from above the tube to gently move the magnetic beads/
cells to the tube wall (Supplementary Figure S1). Critically, this step
was performed with a slow approach of the magnet to minimize
undesirable capture of abnormal cells during the migration of the
magnetic events. Themagnet was initially placed approximately 10
cm above the tube and was then lowered at such a speed that it
made contact with the tube after approximately 1 min. The rocking
motion of the flatbed rocker maintained the lateral movement of
the non-magnetic cells, thus minimizing inappropriate capture.
When in contact with the tube, the magnet was held in place for
30 s to ensure maximum immobilization of the magnetic events;
thereafter, the liquid phase of the sample was transferred to a fresh
50-ml tube. Abnormal cells that may have been caught in the bead
pack were recovered by resuspension of the beads in 14 ml of
priming buffer and two re-isolation steps, as described. The liquid
phases of all three isolations were merged, and candidate events
were purified by centrifugation at 200 g for 5 min. Any resolved
pellet was resuspended in 32 µl of priming buffer.
A 4-µl volume of resuspended pellet was loaded into each of
the microfluidic chambers, and discs were spun on a custom-built
test stand composed of a Cool Muscle CM2-X-56B10A motor
(Muscle Corp., Osaka, Japan) with a custom chuck that was
machined to securely attach discs to the servo-motor shaft. A
desktop PC (Dell, Round Rock, TX, USA) was used to control the
spin speed of the motor. Experimental discs were spun at 12 Hz in
the anti-clockwise direction for 40 min.
Microscopic imaging and analysis of bin occupancy
Following completion of a spincycle, the occupancy of the
collection bins was visualized by differential interference contrast
(DIC) and/or epifluorescence imaging using an inverted
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Figure 1 Description of the centrifugal size-exclusion rail. (a) A single full chamber is schematically represented, highlighting the operational
characteristics and features of interest. The green box shows a magniﬁed section of the critical size-exclusion rail gating entry into two of the
underlying bins, with the direction of a particle travelling along the rail shown with green hatched arrows and the centrifugal ﬁeld shown
with blue and yellow solid arrows. The sizes of the apertures gating entry into each of the bins are listed. The purple box shows a magniﬁed
section of the particle collection bins, with particles of increasing size represented as blue, yellow and red circles. (b) Operation of the size-
exclusion rail. (1) Negative selection of abnormal cells proceeds off-disc in a disposable sample tube. (2) Isolated abnormal cells are loaded in
equal aliquots between eight distinct chambers, marked here as A–H. The direction and centre of rotation of the disc are shown with a white
arrow. (3) At a spin rate of 12 Hz, cellular events travel from the sample-loading reservoir to the size-exclusion rail. Small cells and debris
(blue) enter the ﬁrst bin, but the diameter of larger events will bar them from bin #1, and these will continue along the rail until a sufﬁciently
wide aperture is encountered that will allow passage of the events into the underlying bin. Single cells are shown in green (i), small clusters
are shown in yellow (ii) and larger clusters are shown in red (iii). For clarity, only four chambers are represented.
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epifluorescence microscope (Olympus IX81, Tokyo, Japan). Where
experiments using beads are shown, the distribution was meas-
ured using ImageJ (NIH, Bethesda, MD, USA) by drawing a multi-
point region of interest (ROI) to surround the area occupied by
the beads at the base of the bins. The internal area of this ROI
was then calculated and compared across the eight bins. Where
shown, real-time video of a spinning disc was created from a
series of still images. The polystyrene beads used in the images
and video were supplied pre-coloured from the manufacturer
(Microparticles GmbH, Berlin, Germany).
In cases where cells were stained with NucBlue, the relative
fluorescent signal across the bins was calculated as described
elsewhere36 and as also briefly outlined in the Supplementary
information. For qualitative analysis in which only the binary state
of occupancy was required, the presence of events in each bin
was visually observed using DIC microscopy.
EXPERIMENTAL RESULTS
Size-based binning of beads using the size-exclusion rail
To demonstrate the feasibility of using the size-exclusion rail to
correctly assign events of particular sizes to appropriate bins,
polystyrene bead samples of increasing size were processed, and
the bins to which the beads resolved were analysed. Four bead
diameters (5, 20, 35 and 50 µm) were chosen to represent the
expected size range of cellular clusters and also to test the
aperture widths gating the collection bins of the rail. These beads
were introduced into the loading chamber as homogeneous
samples and were processed by centrifugation, as described in
the “Materials and Methods” section.
Following the resolution of the beads to the capture bins, the
distribution of the various bead sizes was investigated. In general,
the majority of a homogeneous bead population resolved to the
bin whose gate most closely matched the bead size under
analysis (Figure 2a). For example, 87% of the 20-µm beads
resolved to the third bin, accessible via an aperture of 22 µm,
and 79% of the 50-µm beads arrived in the sixth bin after passing
through the 50.6-µm gap in the rail (Figure 2b). Although it would
be expected that the gate aperture must exceed the bead
diameter, certain beads managed to penetrate gates that were
set slightly lower than the bead size. This was observed, for
example, in the case of the sedimentation of 97.1% of the 5-µm
beads in the first bin, which possessed a gate aperture of only
4.7 µm. This finding is most probably attributable to slight
manufacturing tolerance of the posts that composed the rail in
this region. For example, the reported aperture for the first bin
was 4.7 µm based on the original CAD drawing, in which this
value was specified. We chose to report this value for consistency.
When the aperture was measured using scanning electron
microscopy, the actual measurement for the fabricated structured
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Figure 2 Determination of the distribution of polystyrene beads using the size-exclusion rail. (a) Images of the eight capture bins when
homogeneous bead populations of deﬁned size were processed. The area outlined with the blue hatched box is shown. Images representing
bead diameters of 5 µm (blue), 20 µm (yellow), 35 µm (red) and 50 µm (purple) are shown. (b) Bar chart showing the relative distribution of
beads following processing on a size-exclusion rail. The maximum of the scale is 100%. Gate apertures and bin numbers are shown below
the chart. Error bars represent one standard deviation. The data were collected from a total of three chambers run on three separate discs.
(c) Image from a real-time experiment in which a heterogeneous sample composed of 5-µm and 35-µm beads was processed. The 5-µm
beads are shown entering bin #1, whereas the 35-µm beads continue along the rail. All scale bars are 500 µm.
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was 4 ± 2 µm, thus allowing a large number of the particles to
penetrate the rail at this point. Resolution of the 5-μm beads to
the first bin may also have been due to non-uniformity in the
shape of the beads. For example, certain beads may not have
been perfectly spherical and instead may have had a more ovular
cross-section. Nevertheless, despite a degree of sedimentation at
locations ±1 bin from the expected destination, the critical size-
exclusion rail successfully resolved beads of specific sizes to
distinct collection locations. When a heterogeneous sample
composed of 5- and 35-µm beads was processed, both bead
species were directed to the same bins as in the experiments with
monodisperse bead distributions. However, it was observed that
the large beads apparently carried several of the 5-µm beads
towards the 35-µm bin, possibly due to binding of the polystyrene
(Figure 2c). This caveat slightly compromised experiments with more
poly-disperse populations, but as the beads were merely used as
proof of concept, this is not considered to be a restriction of the
device for cell-based applications. A video of the binning of beads is
available in the Supplementary information.
Examination of the clustering potential inherent in specific
cultured cells
As discussed, the size-exclusion rail was designed for the quantifica-
tion of the range and extent of cellular clustering in a blood sample.
To this end, we first validated the basic functionality of the rail by
spiking WBC samples with three cell lines, representing single cells
(HL60, sourced from the Deutsche Sammlung von Mikroorganismen
und Zellkulturen [DSMZ], Braunschweig, Germany) and cells of low
(colo794) or high (sk-mel28) cluster size range (both kind gifts from
Prof. J. O’Leary, Trinity College Dublin, Ireland; Figure 3). Although so
far only the overall fraction of all clusters compared with single cells
has been reported, the current work uniquely quantifies the precise
cluster size distributions for these cell lines.
To examine the capability of the size-exclusion rail to profile
the cluster size from a starting sample of whole blood, individual
aliquots of blood were spiked with homogeneous populations of
NucBlue-stained cell lines (Figure 4). For these experiments,
whole blood samples of 1-ml volume were spiked with 1  103
events. RBCs were lysed, and CD15/CD45-positive cells were
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Figure 3 Detailed cluster size classiﬁcation of the experimental cultured cell lines. (a) Examples of cellular events scored as cluster sizes
ranging from 1 to 8 cells or more cells during the cluster size analysis. The scale bar is 20 µm. (b) Images taken of cell populations for cluster
size analysis for HL60 (single cells), colo794 (low clustering) and sk-mel28 (high clustering). Scale bars are 100 µm. (c) Bar charts representing
the observed range and distribution of cluster sizes for the three cell lines. Error bars represent one standard deviation. The data were
collected for three separate passages of cells.
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Figure 4 Distribution of cellular events according to cluster size fora starting sample of spiked whole blood. (a) Fluorescence data (black
lines) showing the relative ﬂuorescent signal detected in each bin (as a percentage of the total signal detected over the eight bins) per cell
line. These data are overlaid on the bar charts to display the range and distribution of the expected cellular clustering of the three cell lines,
as originally shown in Figure 3. The correlation coefﬁcient between the distributions of ﬂuorescence and cluster size is presented on each
graph. Error bars represent a single standard deviation in the ﬂuorescence distribution and were measured over a total of four individual
chambers run on separate discs. Error bars are shown only for the ﬂuorescence data, so as not to overlap with those of the bar charts; error
bars for the bar charts are shown in Figure 3c. (b) Examples of ﬂuorescent and merged DIC/DAPI images of the capture bins following
processing of blood spiked with ﬂuorescently stained cultured cells. For clarity, ﬂuorescent signals are assigned a blue colour in the merged
images. Magniﬁed images of the bins of interest are shown in the hatched boxes. Scale bars are 500 µm. In both (a) and (b), data pertaining
to HL60, colo794 and sk-mel28 are labelled green, orange and red, respectively.
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removed by negative magnetic isolation, as described in the
“Materials and Methods” section. The isolated abnormal events
were then loaded into the chambers of the experimental disc and
processed by centrifugation. On the completion of the sample
processing, the fluorescence signal from the spiked cells was
measured in each collection bin.
Supplementary Figure S2 shows that when un-spiked and
healthy blood is processed, certain material resolves to bin #1.
As platelets express neither CD15 nor CD45, much of this
background material is assumed to represent a combination of
platelets and debris resulting from the lysis of the RBCs. However,
as it is present in all samples tested but always resolves to bin #1,
this material does not interfere with the search for larger cellular
events in the higher bins. When blood is spiked with single-cell
HL60, these cells are also nearly entirely diverted to bin #1
(Figure 4a and 4b, green labels). This finding is interesting, as the
gate size for bin #1 is 4.7 µm, whereas an average size of 12.4 ±
1.2 µm has been reported for HL60 cells38. This passage of the
larger cells may be linked to the fact that living cells, and HL60
cells in particular39,40, are known to deform under certain
circumstances. Therefore, it is likely that the centrifugal force
suffices to squeeze the HL60 cells through the 4.7-µm aperture.
Supplementary Figure S3 displays an image of an HL60 dimer
after passage through the gate of bin #2. It can be observed
that the width of the aperture is narrower than either the width
or the length of the HL60 dimer, suggesting that the dimer
deformed to penetrate the rail. Although interesting in terms of
deformability, a potential oncogenic marker in and of itself41, the
detection of multi-cellular clusters, as the primary objective of our
work, was not compromised by the resolution of the individual
HL60 cells to bin #1.
Samples were spiked with either the low-range-clustering
colo794 cells or the high-range-clustering sk-mel28 cells; both
cell lines were directed to the higher level bins in addition to bin #1
(Figure 4a and 4b, orange and red labels). Analysis of the
distribution of the fluorescence signal in these bins (Figure 4a,
black lines) revealed that the colo794 cells largely occupied bins
#1–2, with a degree of low occupancy of bin #3. Notably, the
sk-mel28 cells exhibited a fluorescence distribution profile that
spanned from bins #1–8, with the highest peaks for the first and
last bins, thus reflecting the cells’wider distribution of cluster sizes.
When the observed cluster size data for each cell line are overlaid
on the fluorescence distribution data across the capture bins of the
size-exclusion chamber (Figure 4a), a close correlation between the
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expected cluster size and bin occupancy is found. HL60 shows a
near perfect correlation (ρ = 0.9998), as was expected given the
largely single-cell nature of the cell line. Furthermore, colo794
(ρ = 0.99) and sk-mel28 (ρ = 0.95) are strongly correlated, thus
demonstrating that the size-exclusion rail can be used to assess the
tendency towards clustering within a sample based on the
occupancy distribution along the capture bins.
Analysis method for showing the cellular clustering potential
in a sample
Although the data in Figure 4 are based on the measurement
and processing of fluorescence in the collection bins, they are
shown primarily as an example of the performance of the size-
exclusion rail. One of the design aims of binning events to
discrete bins was to facilitate simple interpretation of the data,
without the need for fluorescence or similar specialized micro-
scopy. To this end, inspection of each bin using a simple bright
field microscope (i.e., even without fluorescent light sources or
imagers) allows rapid occupancy scoring of each. As detectable
clustering events are absent in (un-spiked) healthy blood
(Supplementary Figure S2), it is likely that any occupation of
bins to which clusters would resolve is of interest for an
experimental sample. As the candidate events from a sample
are distributed across all disc-based chambers (A–H) and given
that each chamber contains eight collection bins, when the
occupancy profile of the sample is displayed, a two-dimensional
8  8 array will result. To facilitate graphical interpretation,
locations in the array representing void and occupied bins are
coloured green and red, respectively (Figure 5a). Viewing such
an array provides an immediate and easily interpreted indication
of the range of cluster sizes harboured in the sample. For
example, in the case that the array is overwhelmingly green,
with certain areas of red on the right, the array suggests that
there were few events larger than 2–4 cells (i.e., colo794 in
Figure 5a). Conversely, a nearly entirely red array suggests
extensive clustering (i.e., sk-mel28 in Figure 5a).
These data can be further processed from the two-dimensional
array to an one-dimensional profile, if desired. By assigning a
numerical value of 0 to void bins and a value of 1 to occupied
bins, the representative value for each bin address (1–8) can be
calculated by reporting the mean value of each specific bin
address across all of the chambers used. This concept is shown as
the “Event Distribution” in Figure 5b and is sufficient to visualize
the relative load of multi-cellular clusters present in the original
blood sample. Rather than displaying the specific distribution of
cluster sizes, such a single-figure compression of data mirrors the
overall tendency of cells to form clusters of various sizes in the
examined sample and further allows easy comparison of blood
samples (Figure 5b).
SUMMARY AND OUTLOOK
Recent literature has provided strong evidence that the cluster size
distribution in an oncological sample represents a marker of high
diagnostic value. In this work, we developed a novel centrifugal
size-exclusion rail scheme for the examination of the cluster load in
a blood sample, and we demonstrated that samples harbouring
single-cell candidate events (or no candidate events at all) will
exclusively resolve to a given collection bin. When spiking cancer
cells from cell lines with a known propensity to cluster, their
respective tendencies to form clusters are reflected, with high
correlation, by the occupancy distribution across the bins.
We acknowledge that the concentration of target cellular
events that we used in the spiked samples is in excess of that
expected in a real liquid biopsy from a patient; however, our aim
was to present a proof-of-concept strategy for specifically utilizing
a size-exclusion rail to detect and characterize the cluster load in
a blood sample. Continuing work on the size-exclusion rail is
focused on integrating recovery technology developed by our
group to allow arraying and removal of cells/clusters of interest
for specific downstream molecular analysis (these technologies
are detailed in Ref 42 and Ref 43) and also on using the rail to
analyse patient samples, with a particular focus on increasing the
limit of detection for clinical deployment.
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